ChiCTR-SIC-17011273Active, not recruitingPhase 1
中国意义未明单克隆免疫球蛋白增多症患病率的调查
自筹1 site in 1 country1,525 target enrollmentStarted: May 16, 2017Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 1,525
- Locations
- 1
- Primary Endpoint
- 骨髓瘤相关损害
Study Overview
Brief Summary
初步筛查中国人群中 MGUS 的患病率,对阳性患者随访疾病进展的真实状况
Study Design
- Study Type
- 筛查
- Primary Purpose
- 横断面
Eligibility Criteria
- Ages
- 40 to 100 (—)
- Sex
- All
Inclusion Criteria
- •大于等于 40 岁,中国籍贯,住院病人
Exclusion Criteria
- •明确诊断为非“MGUS”的浆细胞病病人
Arms & Interventions
5
Outcomes
Primary Outcomes
骨髓瘤相关损害
Secondary Outcomes
- 年龄、性别等
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
请整合上传所有伦理批件。 中国多发性硬化患者脑脊液免疫球蛋白 G 寡克隆带检测(“CNS-OCB”)的临床研究多发性硬化ChiCTR2000040363研究者自费
Unknown
Not Applicable
全国多中心孕期人群常见单基因病携带者筛查单基因遗传病ChiCTR1800016054深圳华大基因股份有限公司45
Unknown
Not Applicable
静脉注射人免疫球蛋白治疗多灶性运动神经病的探索性临床试验ChiCTR2500106815元羿生物医药科技(上海)有限公司
Unknown
Not Applicable
中国城镇人群自身免疫性大疱病的发病率与患病率调查ChiCTR2300069065北京大学医学部-皮尔法伯集团共建“国家皮肤与免疫疾病临床医学研究中心-皮尔法伯集团-皮肤健康促进协同创新实验室”项目
Not yet recruiting
Not Applicable
Longitudinal study on dengue and Zika infections in KeralaCTRI/2025/07/090539Wellcome Trust28,000
